Alnylam Pharmaceuticals Inc./OS/Call [300]/JPMD
- BID
3.48
- ASK
3.54
- 20,000 Units20,000 Units
- 07/22, 18:29:16 PM
Product class
Warrant - Classic
Last exchange day
19/03/2027
Performance (1M)
3.57%
Basis price
300.0000 [USD]
Cap
- []
Leverage
6.56
Delta
0.52
Agio p.a. in %
28.11 %
Implicit volatility
58.54 %
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 3.57 G | 0 Units |
| PRICE DETERMINATION TIME | 07/22/2026 / 04:35:17 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 3.57 | 3.57 |
| PREV. DAY'S PRICE | 4.05 | (07/21) |
| CHANGE DAY BEFORE | -0.48 | -11.85 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Indicators
| TIME OF CALCULATION | 18:30:24 PM (07/22/2026) |
| AGIO P.A. IN % | 28.11 % |
| LEVERAGE | 6.56 |
| DELTA | 0.52 |
| IMPLICIT VOLATILITY | 58.54 % |
| OMEGA | 3.40 |
| THETA | -0.72 |
| VEGA | 0.08 |
Master Data
| WKN | JE9CS2 |
| ISIN | DE000JE9CS21 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Leverage Product |
| PRODUCT CLASS | Warrant - Classic |
| PRODUCT NAME | Optionsschein auf Alnylam Pharmaceuticals Inc. |
| ISSUER | J.P. Morgan SE |
| TRADING SEGMENT | EUWAX |
| OPTION TYPE | call |
| UNDERLYING | ALNYLAM PHARMACEUTICALS INC COM USD0.01 |
| BASIS PRICE | 300.0000 [USD] |
| CAP | - [] |
| KNOCKIN LEVEL | - [-] |
| RANGE | - - - |
| MULTIPLIER | 0.10 |
| EXERCISE TYPE | American |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | EUR |
| SETTLEMENT CURRENCY | Euro |
| SMALLEST TRADABLE UNIT | 1.00 |
| MINIMUM QUOTATION EUR | 3,000.00 |
| MINIMUM QUOTATION UNITS | 10,000.00 |
| LAST VALUATION DAY | 19/03/2027 |
| PAYMENT DATE | 30/03/2027 |
| FIRST EXCHANGE DAY | 15/05/2026 |
| LAST EXCHANGE DAY | 19/03/2027 |
| TRADING HOURS | 08:00:00 AM - 10:00:00 PM |
| QUOTATION | fortlaufende Auktion |
| ISSUE VOLUME | 30,000,000 |
| QUANTO | No |
Underlying
| WKN | A0CBCK |
| ISIN | US02043Q1076 |
| SYMBOL | DUL |
| NOMINAL CURRENCY | Euro |
| TYPE OF UNDERLYING | Equity |
| COUNTRY OF THE HOME STOCK EXCHANGE | Germany |
Issuer
| NAME | J.P. Morgan SE |
| ADDRESS | J.P. Morgan SE
Taunustor 1 (Taunusturm)
60310 Frankfurt am Main
Deutschland |
| EMAIL ADDRESS | kontakt.zertifikate@jpmorgan.com |
| SERVICE PHONE NUMBER | 069 71240 |
| URL | https://jpmorgan-zertifikate.de |
| DOCUMENTS | PRIIP / KID (english) |
Product Description
This (call) warrant is linked to Alnylam Pharmaceuticals Inc., the underlying instrument, and has a term ending on March 30, 2027. This is a leveraged product, where the investor participates disproportionately in the positive and negative performance of the underlying. The investor has the right to exercise throughout the term of the warrant. Upon exercise, the redemption amount is calculated as the difference between the price of the underlying and the strike price, adjusted for the multiplier of 0.10. Exercise occurs automatically at the end of the term. If, at that point in time, the price of the underlying is below the strike price, the product will expire worthless.